Feasibility and Preliminary Results of Intensive Chemotherapy and Extensive Irradiation in Selected Patients with Limited Small-Cell Lung Carcinoma: Results of Three Consecutive Phase II Programs

Author： Tourani Jean Marc   Jaillon-Abraham Christine   Coscas Yvan   Dabouis Gerard   Andrieu Jean Marie  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.39, Iss.4, 2000-10, pp. : 501-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-operative Chemoradiotherapy in Non-small Cell Lung Cancer Stage III Patients. Feasibility, Toxicity and Long-term Results of a Phase II Study

By Favaretto A.   Paccagnella A.   Tomio L.   Sartori F.   Cipriani A.   Zuin R.   Reffosco L.   Calabro' F.   Rea F.   Ghiotto C.   Chiarion-Sileni V.   Oniga F.   Loreggian L.   Fiorentino M.V.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2064-2069

Elsevier

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of chemotherapy in limited-disease small-cell lung cancer

By Kenmotsu Hirotsugu  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 483-492

Future Medicine

Access to resources Recommend Favorite

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite